
Sign up to save your podcasts
Or


We discuss the first interim results of a novel intravitreal gene therapy agent, 4D-150, with Dr. Arshad Khanani of Sierra Eye Associates and the University of Nevada Reno School of Medicine.
By Retina Synthesis4.5
88 ratings
We discuss the first interim results of a novel intravitreal gene therapy agent, 4D-150, with Dr. Arshad Khanani of Sierra Eye Associates and the University of Nevada Reno School of Medicine.

43 Listeners

18 Listeners

99 Listeners

112,909 Listeners

56,984 Listeners

5 Listeners

9,571 Listeners

11 Listeners

47,985 Listeners

51 Listeners

11 Listeners

466 Listeners

19 Listeners

0 Listeners